Potential treatment target in fatty liver disease identified

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that may lead to better disease management and…

Continue Reading

News Source: medicalxpress.com